Clinical Diagnostics News and Research

RSS
Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Sphere Medical publishes white paper discussing areas where Proxima mitigates sources of pre-analytical errors

Sphere Medical publishes white paper discussing areas where Proxima mitigates sources of pre-analytical errors

QIAGEN's therascreen EGFR RGQ PCR Kit to guide use of IRESSA for in NSCLC treatment

QIAGEN's therascreen EGFR RGQ PCR Kit to guide use of IRESSA for in NSCLC treatment

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

Bio-Techne to acquire 100% ownership of Cliniqa

Bio-Techne to acquire 100% ownership of Cliniqa

Turkey steadily emerges as one of hottest healthcare markets in the world

Turkey steadily emerges as one of hottest healthcare markets in the world

Max Planck Institute researchers find protein profiles of DNA repair

Max Planck Institute researchers find protein profiles of DNA repair

PAML signs collaborative agreement with Axela

PAML signs collaborative agreement with Axela

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

A beginner’s guide to CRISPR genome editing

A beginner’s guide to CRISPR genome editing

Quest Diagnostics grants Supplier Excellence Awards to five companies

Quest Diagnostics grants Supplier Excellence Awards to five companies

IDT supports unique bioengineering public outreach program

IDT supports unique bioengineering public outreach program

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients